Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives
Friedenson, B.; Friedenson, H.
Medgenmed Medscape General Medicine 4(3): 3
2002
ISSN/ISBN: 1531-0132 PMID: 12466746 Document Number: 545064
Document emailed within 1 workday
Related Documents
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539Freund, R.; Kelsberg, G.; Safranek, S. 2014: Clinical Inquiry: do oral contraceptives put women with a family history of breast cancer at increased risk? Journal of Family Practice 63(9): 540; 549
Freund, R.; Kelsberg, G.; Safranek, S. 2014: Clinical Inquiry: do oral contraceptives put women with a family history of breast cancer at increased risk? Journal of Family Practice 63(9): 540; 549
Rookus, M.A.; van Leeuwen, F.E. 1994: Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group Lancet 344(8926): 844-851
Rookus, M.A.; van Leeuwen, F.E. 1994: Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group Lancet 344(8926): 844-851
Gaffield, M.E.; Culwell, K.R.; Ravi, A. 2009: Oral contraceptives and family history of breast cancer Contraception 80(4): 372-380
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Moorman, P.G.; Havrilesky, L.J.; Gierisch, J.M.; Coeytaux, R.R.; Lowery, W.J.; Peragallo Urrutia, R.; Dinan, M.; McBroom, A.J.; Hasselblad, V.; Sanders, G.D.; Myers, E.R. 2013: Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(33): 4188-4198
Ichida, M.; Kataoka, A.; Tsushima, R.; Taguchi, T. 2015: No increase in breast cancer risk in Japanese women taking oral contraceptives: a case-control study investigating reproductive, menstrual and familial risk factors for breast cancer Asian Pacific Journal of Cancer Prevention: Apjcp 16(9): 3685-3690
Rybchenko, L.A.; Bychkova, A.M.; Skyban, G.V.; Klymenko, S.V. 2013: Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 18: 253-260
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Reynolds, T.M.; Wierzbicki, A.S. 2003: Does evidence-based medicine provide evidence? The evidence on breast cancer and the safety of oral contraceptives suggests that unorthodox interpretations may be just as valid Breast Journal 9(1): 66-67
Ferris, J.S.; Daly, M.B.; Buys, S.S.; Genkinger, J.M.; Liao, Y.; Terry, M.B. 2014: Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry British Journal of Cancer 110(4): 1074-1080
Milsom, I.; Odlind, V. 2008: Oral contraceptives give long-lasting protection against ovarian cancer. use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden Lakartidningen 105(10): 715-716
Bui, K.T.; Wakefield, C.E.; Kasparian, N.A.; Tyler, J.; Abbott, J.; Tucker, K. 2013: Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes Psycho-Oncology 22(1): 228-232
Petrakis, N.L.; Ernster, V.L.; King, E.B.; Sacks, S.T. 1982: Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors Journal of the National Cancer Institute 68(1): 9-13
Walker, G.R.; Schlesselman, J.J.; Ness, R.B. 2002: Family history of cancer, oral contraceptive use, and ovarian cancer risk American Journal of Obstetrics and Gynecology 186(1): 8-14
Drill, V.A. 1975: Oral contraceptives: relations to mammary cancer, benign breast lesions, and cervical cancer Annual Review of Pharmacology 15: 367-385
Xu, W-Hong.; Shu, X-Ou.; Long, J.; Lu, W.; Cai, Q.; Zheng, Y.; Xiang, Y-Bing.; Dai, Q.; Zhao, G-Ming.; Gu, K.; Bao, P-Ping.; Gao, Y-Tang.; Zheng, W. 2011: Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women American Journal of Epidemiology 173(8): 923-931
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107